These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Parathyroid hormone-related protein in patients with malignant melanoma. Elias AN; Pandian MR; Jacowatz J Arch Dermatol; 1992 Feb; 128(2):278-9. PubMed ID: 1739318 [No Abstract] [Full Text] [Related]
23. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539 [TBL] [Abstract][Full Text] [Related]
25. The relation between serum calcium and tumor metastases. Gardner B Surg Gynecol Obstet; 1969 Feb; 128(2):369-74. PubMed ID: 4887444 [No Abstract] [Full Text] [Related]
26. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism. Firek AF; Kao PC; Heath H J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510 [TBL] [Abstract][Full Text] [Related]
27. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma. Amer MH; Al-Sarraf M; Vaitkevicius VK Surg Gynecol Obstet; 1979 Nov; 149(5):687-92. PubMed ID: 505243 [TBL] [Abstract][Full Text] [Related]
28. Calcium metabolism in cancer. Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin. Coombes RS; Ward MK; Greenberg PB; Hillyard CJ; Tulloch BR; Morrison R; Joplin GF Cancer; 1976 Nov; 38(5):2111-20. PubMed ID: 186180 [TBL] [Abstract][Full Text] [Related]
29. Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome. Gómez-León N; Pacheco-Barcia V; Ballesteros AI; Fraga J; Colomer R; Friera A Melanoma Res; 2018 Dec; 28(6):562-570. PubMed ID: 29975212 [TBL] [Abstract][Full Text] [Related]
30. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism. Law WM; Bollman S; Kumar R; Heath H J Clin Endocrinol Metab; 1984 Apr; 58(4):744-7. PubMed ID: 6699136 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary stenosis due to metastatic malignant melanoma. Güray Y; Tuncel C; Sakaoğullari Z; Boyaci A; Birincioğlu L Anadolu Kardiyol Derg; 2010 Feb; 10(1):E3. PubMed ID: 20149994 [No Abstract] [Full Text] [Related]
32. Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma. Wagner RF; Nathanson L J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):249-56. PubMed ID: 2869074 [TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia after renal transplantation. Schwartz GH; David DS; Riggio RR; Saville PD; Whitsell JC; Stenzel KH; Rubin AL Am J Med; 1970 Jul; 49(1):42-51. PubMed ID: 4914475 [No Abstract] [Full Text] [Related]
34. Hypercalcemia associated with cancer of prostate without bony metastases. Barkin J; Crassweller PO; Roncari DA; Onrot J Urology; 1984 Oct; 24(4):368-71. PubMed ID: 6485198 [TBL] [Abstract][Full Text] [Related]
35. Thyrotoxicosis, hypercalcemia, and secondary hyperparathyroidism. Barsotti MM; Targovnik JH; Verso TA Arch Intern Med; 1979 Jun; 139(6):661-3. PubMed ID: 443969 [TBL] [Abstract][Full Text] [Related]
36. Calcinosis in nonparathyroid malignant disease: an unusual case report and clinicopathologic review of 17 cases. Hall SW; Luna MA; Bedrossian C; Rodriquez V Med Pediatr Oncol; 1978; 4(1):49-58. PubMed ID: 625263 [TBL] [Abstract][Full Text] [Related]
37. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism? Bargren AE; Repplinger D; Chen H; Sippel RS J Am Coll Surg; 2011 Sep; 213(3):410-4. PubMed ID: 21723154 [TBL] [Abstract][Full Text] [Related]
38. Pseudohyperparathyroidism due to malignant melanoma. Menguy R Surg Clin North Am; 1969 Feb; 49(1):49-56. PubMed ID: 5791825 [No Abstract] [Full Text] [Related]